NCT07764380

Brief Summary

The aim of this study is to evaluate the effects of stress management and epigenetic awareness training provided in prenatal classes on maternal stress levels, cortisol levels, and epigenetic awareness. The main questions it aims to answer are:

  1. 1.Do stress management and epigenetic awareness training provided in prenatal classes affect pregnant women's cortisol levels?
  2. 2.Does the training affect pregnant women's knowledge and awareness of epigenetic effects?

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable pregnancy

Timeline
4mo left

Started May 2026

Shorter than P25 for not_applicable pregnancy

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress43%
May 2026Dec 2026

First Submitted

Initial submission to the registry

April 16, 2026

Completed
29 days until next milestone

Study Start

First participant enrolled

May 15, 2026

Completed
3 months until next milestone

First Posted

Study publicly available on registry

August 13, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2026

Last Updated

August 13, 2026

Status Verified

August 1, 2026

Enrollment Period

4 months

First QC Date

April 16, 2026

Last Update Submit

August 11, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Assessment of Pregnancy-Related Stress

    The Pregnancy Stress Assessment Scale , used to identify pregnancy-related stress factors in pregnant women. The scale consists of 36 items and 5 subscales. Range from a minimum of 0 to a maximum of 144 points. Higher scores on the scale are interpreted as indicating increased stress.

    Pregnancy Stress Assessment Scale will be administered to all pregnant women in both groups at the first interview (day 1)

  • Assessment of Pregnancy-Related Stress

    The Pregnancy Stress Assessment Scale , used to identify pregnancy-related stress factors in pregnant women. The scale consists of 36 items and 5 subscales. Range from a minimum of 0 to a maximum of 144 points. Higher scores on the scale are interpreted as indicating increased stress.

    Pregnancy Stress Assessment Scale will be administered to all pregnant women in both groups at the first interview (At the end of Week 3)

Secondary Outcomes (4)

  • Measuring pregnant women's awareness of epigenetic effects and stress

    Epigenetic Awareness and Information Form will be administered to all pregnant women in both groups at the first interview (day 1)

  • Measuring pregnant women's awareness of epigenetic effects and stress

    Epigenetic Awareness and Information Form will be administered to all pregnant women in both groups at the first interview (At the end of Week 3)

  • Cortisol level measurement

    Salivary cortisol level will be administered to all pregnant women in both groups at the first interview (day 1)

  • Cortisol level measurement

    Salivary cortisol level will be administered to all pregnant women in both groups at the first interview (At the end of Week 3)

Study Arms (2)

Education group

EXPERIMENTAL

The Maternal Epigenetics Training Module will be conducted over a three-week period, consisting of a total of three sessions held once a week. The training will include an informational presentation covering stress management, the potential effects of stress during pregnancy on the mother, the potential effects of stress during pregnancy on the fetus, epigenetic mechanisms, and the impact of the mother's lifestyle on fetal health.

Behavioral: Maternal Epigenetics Training Module

Control

NO INTERVENTION

The standard group that did not participate in the Maternal Epigenetics Training Module.

Interventions

The Maternal Epigenetics Education Module is a structured educational intervention designed to reduce stress levels in expectant mothers during pregnancy, raise their awareness of the effects of stress on both the mother and the fetus, and promote healthy lifestyle behaviors within the framework of epigenetic mechanisms. The module addresses the relationship between stress, epigenetics, and fetal health during pregnancy from a scientific perspective and aims to equip expectant mothers with basic skills for managing stress.

Education group

Eligibility Criteria

Age18 Years - 49 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Pregnant women aged 18 and older
  • Pregnant women in any trimester of pregnancy
  • Pregnant women who can read and understand Turkish
  • Pregnant women who voluntarily agree to participate in the study
  • Having a singleton pregnancy
  • Pregnant women without a high-risk pregnancy
  • Pregnant women who voluntarily participate in prenatal education classes will be included.

You may not qualify if:

  • Foreign nationals with communication difficulties,
  • Multiple pregnancies,
  • Illiterate pregnant women,
  • Migrant pregnant women who do not speak Turkish,
  • Pregnant women with high-risk pregnancies,
  • Pregnant women not enrolled in prenatal education programs,
  • Pregnant women with intellectual disabilities,
  • Pregnant women who refuse to participate in the study will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Emine Aksüt Akçay

Kahramanmaraş, Turkey (Türkiye)

RECRUITING

Kahramanmaras Sutcu Imam University

Kahramanmaraş, Turkey (Türkiye)

RECRUITING

Related Publications (1)

  • Dieckmann L, Czamara D. Epigenetics of prenatal stress in humans: the current research landscape. Clin Epigenetics. 2024 Feb 2;16(1):20. doi: 10.1186/s13148-024-01635-9.

    PMID: 38308342BACKGROUND

Related Links

Study Officials

  • ESRA KARATAŞ OKYAY, PhD

    Kahramanmaras Sutcu Imam University

    STUDY CHAIR

Central Study Contacts

İsmail Gürkan Çıkım, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: Randomized controlled trial conducted with experimental and control groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD, Assistant Professor

Study Record Dates

First Submitted

April 16, 2026

First Posted

August 13, 2026

Study Start

May 15, 2026

Primary Completion (Estimated)

September 15, 2026

Study Completion (Estimated)

December 15, 2026

Last Updated

August 13, 2026

Record last verified: 2026-08

Locations